Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid... see more

OTCPK:TRPXY - Post Discussion

View:
Post by easyas123 on Mar 13, 2019 2:49pm

Cure Pharma

Anyone keeping tabs on Cure Pharma, market cap sitting at $115M. A merger with TRPX could make a lot more sense at these prices.
Comment by Fundy13 on Mar 14, 2019 4:43pm
We are getting close tot he three month mark since the HUGE deal was terminated.  Would be nice to hear an update of some sort soon.  I have predicted since Dec that we would hear somethign before the end of March.   We could also get updates on some of the trials soom as well.  With the low float when this thing moves it will be quick.
Comment by easyas123 on Mar 14, 2019 10:14pm
Just read on FSD page that TRPX has hired Rupert Haynes as a consultant. Very interesting.
Comment by Fundy13 on Mar 15, 2019 7:31am
I do not see any evidence that this is true
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities